Oslo, April 30, 2021 - Observe Medical ASA (OSE:OBSRV): Attached Observe Medical
ASA`s annual report for 2020. The report is also available on the company's
website, www.observemedical.com

The annual report was reviewed and approved by the board of directors on April
29, 2021. The financial statements included in the annual report has no
significant changes since the preliminary results for the full year 2020
reported on February 23, 2021.

For further information, please contact:

Björn Larsson, CEO. Mobile: +46 76 620 17 25 E
-mail: bjorn.larsson@observemedical.com

Per Arne Nygård, CFO Mobile: +47 411 04 345 E
-mail: perarne.nygard@observemedical.com



About Observe Medical

Observe Medical develops and markets and sells innovative hospital products that
contribute to increased patient safety and a more efficient care system. The
company's ambition is to drive growth by leveraging its expertise in sales and
commercialization of its broad portfolio of medical technology products, mainly
in the areas of Urine measurement, Anesthesiology/ICUs and wound care, in
combination with targeted M&A. The company's headquarter is in Oslo, Norway and
its operations is based out of Gothenburg, Sweden. Observe Medical has a direct
sales organization in the Nordics and a distributor network internationally.
Observe Medical's product Sippi® is the only automated digital urine meter with
possibility for wireless data transfer to the hospital patient data management
systems and hinders bacterial migration that can lead to urinary infections
(Sippcoat®). Sippi® is CE marked and is currently being launched with focus on
selected markets and hospitals in Nordics and in Europe.